ADRUCIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Adrucil, and what generic alternatives are available?
Adrucil is a drug marketed by Pharmacia And Upjohn and Teva Parenteral and is included in four NDAs.
The generic ingredient in ADRUCIL is fluorouracil. There are fifteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Adrucil
A generic version of ADRUCIL was approved as fluorouracil by FRESENIUS KABI USA on September 30th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ADRUCIL?
- What are the global sales for ADRUCIL?
- What is Average Wholesale Price for ADRUCIL?
Summary for ADRUCIL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 215 |
Clinical Trials: | 80 |
Patent Applications: | 3,113 |
DailyMed Link: | ADRUCIL at DailyMed |
Recent Clinical Trials for ADRUCIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kimberly Perez | Phase 2 |
Colin D. Weekes, M.D. | Phase 1 |
Daiichi Sankyo, Inc. | Phase 2 |
US Patents and Regulatory Information for ADRUCIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | ADRUCIL | fluorouracil | INJECTABLE;INJECTION | 081222-001 | Jun 28, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Parenteral | ADRUCIL | fluorouracil | INJECTABLE;INJECTION | 081225-001 | Aug 28, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmacia And Upjohn | ADRUCIL | fluorouracil | INJECTABLE;INJECTION | 017959-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Parenteral | ADRUCIL | fluorouracil | INJECTABLE;INJECTION | 040023-001 | Oct 18, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |